Oxygenta Pharmaceutical Ltd vs Phaarmasia Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: May 05, 2026

Key Highlights

The Latest Trading Price of Oxygenta Pharmaceutical Ltd is ₹ 55.21 as of 05 May 15:30 . The P/E Ratio of Oxygenta Pharmaceutical Ltd changed from 0 on March 2021 to 0 on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe P/E Ratio of Phaarmasia Ltd changed from 54 on March 2021 to 0 on March 2025 . This represents a CAGR of -100.00% over 5 years The Market Cap of Oxygenta Pharmaceutical Ltd changed from ₹ 34.15 crore on March 2022 to ₹ 294.24 crore on March 2025 . This represents a CAGR of 71.33% over 4 yearsThe Market Cap of Phaarmasia Ltd changed from ₹ 16.97 crore on March 2021 to ₹ 20.02 crore on March 2025 . This represents a CAGR of 3.36% over 5 years The revenue of Oxygenta Pharmaceutical Ltd for the Dec '25 is ₹ 33.93 crore as compare to the Sep '25 revenue of ₹ 14.25 crore. This represent the growth of 138.11% The revenue of Phaarmasia Ltd for the Dec '25 is ₹ 35.21 crore as compare to the Sep '25 revenue of ₹ 16.69 crore. This represent the growth of 110.96% The ebitda of Oxygenta Pharmaceutical Ltd for the Dec '25 is ₹ -4.08 crore as compare to the Sep '25 ebitda of ₹ -4.63 crore. This represent the decline of -11.88% The ebitda of Phaarmasia Ltd for the Dec '25 is ₹ 19.99 crore as compare to the Sep '25 ebitda of ₹ 1.75 crore. This represent the growth of 1042% The net profit of Oxygenta Pharmaceutical Ltd changed from ₹ -1.36 crore to ₹ -4.84 crore over 7 quarters. This represents a CAGR of 106.55% The net profit of Phaarmasia Ltd changed from ₹ 0.28 crore to ₹ 16.27 crore over 7 quarters. This represents a CAGR of 918.90% The Dividend Payout of Oxygenta Pharmaceutical Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe Dividend Payout of Phaarmasia Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 years .

About Oxygenta Pharmaceutical Ltd

Oxygenta Pharmaceutical Limited was initially incorporated as S S Organics Private Limited as a private limited Company in 1990.
The Company converted its status to a Public Limited Company in 1993 changing the name to S S Organics Limited.
Further, it was changed to Oxygenta Pharmaceutical Limited in FY 2021-22. The Company was incorporated with the objective of carrying on the business of manufacturing all classes and kinds of Drugs including Pharmaceutical preparation, and Organic Fine Chemicals.
It manufactures a wide range of new generation quinolones, antiasthmatic, antiulcerant, and anti-inflammatory drugs.
The Company has plant located at Medak in Andhra Pradesh. The Company is strong in manufacturing of anti ulcerative and anti bacterial drugs.

About Phaarmasia Ltd

Incorporated in 1981, Phaarmasia Limited (unit-I) is the part of the Maneesh Pharmaceutical Limited, with its headquarters and marketing office in Mumbai.
M/s Phaarmasia Limited Unit-II was established in 1993-94.
The Company is engaged in manufacturing and marketing of Oral contraceptive tablets' with various therapeutic dosage combinations along with iron tablets for Ministry of Health & Family Welfare and for Exports. The plant is situated in a hygienic environment; free from dust, smoke, chemical & biological emission.
Phaarmasia Ltd. Is an independent State-of-the-art-manufacturing unit having manufacturing facility of international standards with manufacturing capacity of more than 30 million units per annum. During the year 2000, the company became a Sick Industrial Company under SICA and therefore the same was referred to the BIFR.

FAQs for the comparison of Oxygenta Pharmaceutical Ltd and Phaarmasia Ltd

Which company has a larger market capitalization, Oxygenta Pharmaceutical Ltd or Phaarmasia Ltd?

Market cap of Oxygenta Pharmaceutical Ltd is 204 Cr while Market cap of Phaarmasia Ltd is 67 Cr

What are the key factors driving the stock performance of Oxygenta Pharmaceutical Ltd and Phaarmasia Ltd?

The stock performance of Oxygenta Pharmaceutical Ltd and Phaarmasia Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Oxygenta Pharmaceutical Ltd and Phaarmasia Ltd?

As of May 5, 2026, the Oxygenta Pharmaceutical Ltd stock price is INR ₹55.21. On the other hand, Phaarmasia Ltd stock price is INR ₹98.16.

How do dividend payouts of Oxygenta Pharmaceutical Ltd and Phaarmasia Ltd compare?

To compare the dividend payouts of Oxygenta Pharmaceutical Ltd and Phaarmasia Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.